• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cancer Prevalence in Aichi, Japan for 2012: Estimates Based on Incidence and Survival Data from Population-Based Cancer Registry.2012年日本爱知县癌症患病率:基于人群癌症登记处发病率和生存数据的估计
Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2151-2156. doi: 10.22034/APJCP.2017.18.8.2151.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.《2014年意大利癌症数据报告:意大利癌症的患病率与治愈率》
Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 1):1-122. doi: 10.19191/EP14.6.S1.113.
4
Estimates of cancer burden in Sardinia.撒丁岛癌症负担的估计。
Tumori. 2013 May-Jun;99(3):408-15. doi: 10.1177/030089161309900317.
5
Estimation of cancer incidences in Aichi prefecture: use of a model area with good quality registry data.爱知县癌症发病率的估计:利用具有高质量登记数据的模型区域
Asian Pac J Cancer Prev. 2004 Jul-Sep;5(3):320-7.
6
Estimates of cancer burden in Lazio.拉齐奥地区癌症负担的估计。
Tumori. 2013 May-Jun;99(3):359-65. doi: 10.1177/030089161309900311.
7
Estimates of cancer burden in Tuscany.托斯卡纳地区癌症负担的估计。
Tumori. 2013 May-Jun;99(3):334-41. doi: 10.1177/030089161309900308.
8
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.基于监测、流行病学和最终结果(SEER)计划中肿瘤登记数据的癌症患病率估计。
Int J Epidemiol. 2000 Apr;29(2):197-207. doi: 10.1093/ije/29.2.197.
9
Italian cancer figures, report 2013: Multiple tumours.《2013年意大利癌症数据报告:多发性肿瘤》
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.
10
Estimates of cancer burden in Veneto.威尼托地区癌症负担的估计。
Tumori. 2013 May-Jun;99(3):308-17. doi: 10.1177/030089161309900305.

引用本文的文献

1
Five-year survival rate of kidney cancer (localized renal cell carcinoma) in the Asia: A systematic review and meta-analysis.亚洲肾癌(局限性肾细胞癌)的五年生存率:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Aug 22;104(34):e43867. doi: 10.1097/MD.0000000000043867.
2
Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study.亚洲国家甲状腺癌的生存率:一项系统评价和荟萃分析研究。
Endocrine. 2023 Nov;82(2):237-249. doi: 10.1007/s12020-023-03408-5. Epub 2023 Jun 3.
3
Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer.对各期胰腺癌患者经内镜获取的组织进行下一代测序。
Cancer Sci. 2022 Mar;113(3):1069-1077. doi: 10.1111/cas.15249. Epub 2022 Jan 10.
4
Digital next-generation sequencing of cell-free DNA for pancreatic cancer.用于胰腺癌的游离DNA数字下一代测序
JGH Open. 2021 Mar 22;5(4):508-516. doi: 10.1002/jgh3.12530. eCollection 2021 Apr.
5
Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens.经内镜获取的胰腺癌标本中遗传改变的临床意义。
Cancer Med. 2021 Feb;10(4):1264-1274. doi: 10.1002/cam4.3723. Epub 2021 Jan 16.
6
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.亚洲国家肝细胞癌的生存率:一项系统评价与荟萃分析。
EXCLI J. 2020 Jan 13;19:108-130. doi: 10.17179/excli2019-1842. eCollection 2020.
7
Cancer prevalence among the rural poverty-stricken population in Northeast China.中国东北地区农村贫困人口中的癌症患病率。
Cancer Manag Res. 2019 May 31;11:5101-5112. doi: 10.2147/CMAR.S205867. eCollection 2019.
8
The Prefectural Participation Rates of Lung Cancer Screening Had a Negative Correlation with the Lung Cancer Mortality Rates.肺癌筛查的县级参与率与肺癌死亡率呈负相关。
Asian Pac J Cancer Prev. 2019 Mar 26;20(3):855-861. doi: 10.31557/APJCP.2019.20.3.855.

本文引用的文献

1
The impact of long-term follow-up care for childhood cancer survivors: A systematic review.儿童癌症幸存者长期随访护理的影响:一项系统综述。
Crit Rev Oncol Hematol. 2017 Jun;114:131-138. doi: 10.1016/j.critrevonc.2017.04.007. Epub 2017 Apr 13.
2
Time Trends in Histological Features of Latent Prostate Cancer in Japan.日本潜伏性前列腺癌组织学特征的时间趋势
J Urol. 2016 May;195(5):1415-1420. doi: 10.1016/j.juro.2015.11.068. Epub 2015 Dec 8.
3
Arrival of a new era in Japan with the establishment of the Cancer Registration Promotion Act.随着《癌症登记促进法》的制定,日本迎来了一个新时代。
Eur J Cancer Prev. 2015 Nov;24(6):542-3. doi: 10.1097/CEJ.0000000000000095.
4
Lead time bias in estimating survival outcomes.估计生存结局时的领先时间偏倚。
Gut. 2016 Mar;65(3):538-9. doi: 10.1136/gutjnl-2015-310199. Epub 2015 Jul 10.
5
Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.2009年日本的癌症发病率及发生率:针对日本癌症发病率监测(MCIJ)项目的32个基于人群的癌症登记处的研究。
Jpn J Clin Oncol. 2015 Sep;45(9):884-91. doi: 10.1093/jjco/hyv088. Epub 2015 Jul 3.
6
Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.《五大洲癌症发病率》:纳入标准、第十卷要点及全球癌症登记现状。
Int J Cancer. 2015 Nov 1;137(9):2060-71. doi: 10.1002/ijc.29670.
7
Conceptualizing overdiagnosis in cancer screening.癌症筛查中过度诊断的概念化。
J Natl Cancer Inst. 2015 Feb 6;107(4). doi: 10.1093/jnci/djv014. Print 2015 Apr.
8
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
9
Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data.利用基于人群的癌症登记数据对日本癌症患者的长期生存和条件生存情况进行研究。
Cancer Sci. 2014 Nov;105(11):1480-6. doi: 10.1111/cas.12525. Epub 2014 Oct 18.
10
Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.2008 年日本癌症发病与发病专率:日本癌症发病率监测项目(MCIJ)中 25 个基于人群的癌症登记处的研究。
Jpn J Clin Oncol. 2014 Apr;44(4):388-96. doi: 10.1093/jjco/hyu003. Epub 2014 Feb 5.

2012年日本爱知县癌症患病率:基于人群癌症登记处发病率和生存数据的估计

Cancer Prevalence in Aichi, Japan for 2012: Estimates Based on Incidence and Survival Data from Population-Based Cancer Registry.

作者信息

Nakagawa-Senda Hiroko, Yamaguchi Michiyo, Matsuda Tomohiro, Koide Kayoko, Kondo Yoshinobu, Tanaka Hideo, Ito Hidemi

机构信息

Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Japan. Email:

出版信息

Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2151-2156. doi: 10.22034/APJCP.2017.18.8.2151.

DOI:10.22034/APJCP.2017.18.8.2151
PMID:28843249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5697474/
Abstract

Background: Cancer is the leading cause of death among both men and women in Japan. Monitoring cancer prevalence is important because prevalence data play a critical role in the development and implementation of health policy. We estimated cancer prevalence in 2012 based on cancer incidence and 5-year survival rate in Aichi Prefecture using data from a population-based cancer registry, the Aichi Cancer Registry, which covers 7.4 million people. Methods: The annual number of incident cases between 2008 and 2012 was used. Survival data of patients diagnosed in 2006–2008 and followed up until the end of 2012 were selected for survival analysis. Cancer prevalence was estimated from incidence and year-specific survival probabilities. Cancer prevalence was stratified by sex, cancer site (25 major cancers), and age group at diagnosis. Results: The estimated prevalence for all cancers in 2012 was 68,013 cases among men, 52,490 cases among women, with 120,503 cases for both sexes. Colorectal cancer was the most incident cancer with 6,654 cases, accounting for 16.0% of overall incident cases, followed by stomach cancer with 5,749 cases (13.8%) and lung cancer with 5,593 cases (13.4%). Prostate cancer was the most prevalent among men, accounting for 21.5%, followed by colorectal and stomach cancers. Breast cancer was the most prevalent among women, accounting for 28.6%, followed by colorectal, stomach, and uterine cancers. Conclusion: This study provides cancer prevalence data that could serve as useful essential information for local governments in cancer management, to carry out more practical and reasonable countermeasures for cancer.

摘要

背景

在日本,癌症是男性和女性的主要死因。监测癌症患病率很重要,因为患病率数据在卫生政策的制定和实施中起着关键作用。我们利用基于人群的癌症登记处——爱知癌症登记处(覆盖740万人)的数据,根据爱知县2012年的癌症发病率和5年生存率估算了癌症患病率。

方法

使用2008年至2012年的年度发病病例数。选择2006 - 2008年诊断并随访至2012年底的患者生存数据进行生存分析。根据发病率和特定年份的生存概率估算癌症患病率。癌症患病率按性别、癌症部位(25种主要癌症)和诊断时的年龄组进行分层。

结果

2012年所有癌症的估算患病率男性为68,013例,女性为52,490例,男女合计为120,503例。结直肠癌是发病最多的癌症,有6,654例,占总发病病例的比例为16.0%,其次是胃癌,有5,749例(13.8%)和肺癌,有5,593例(13.4%)。前列腺癌在男性中患病率最高,占21.5%,其次是结直肠癌和胃癌。乳腺癌在女性中患病率最高,占28.6%,其次是结直肠癌、胃癌和子宫癌。

结论

本研究提供的癌症患病率数据可作为地方政府癌症管理的有用基础信息,以便针对癌症采取更切实合理的应对措施。